Neumora Therapeutics (NMRA) Institutional Ownership $1.76 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.74 -0.02 (-1.08%) As of 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Neumora Therapeutics (NASDAQ:NMRA)CurrentInstitutional OwnershipPercentage47.65%Number ofInstitutional Buyers(last 12 months)70TotalInstitutional Inflows(last 12 months)$104.66MNumber ofInstitutional Sellers(last 12 months)23TotalInstitutional Outflows(last 12 months)$50.85M Get NMRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Neumora Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data NMRA Institutional Buying and Selling by Quarter Neumora Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Bridgeway Capital Management LLC125,000$92K0.0%N/A0.077% 8/15/2025 Bank of America Corp DE71,380$52K0.0%-91.8%0.044% 8/14/2025 Canada Pension Plan Investment Board55,700$41K0.0%N/A0.034% 8/14/2025 Sei Investments Co.213,862$157K0.0%N/A0.132% 8/14/2025 RBF Capital LLC160,000$117K0.0%N/A0.099% 8/14/2025 Cerity Partners LLC324,219$238K0.0%+7.2%0.200% 8/14/2025 Federated Hermes Inc.314,119$230K0.0%+10.4%0.194% 8/13/2025 Marshall Wace LLP250,490$183K0.0%N/A0.155% 8/13/2025 Invesco Ltd.132,038$97K0.0%+6.8%0.082% 8/13/2025 Russell Investments Group Ltd.73,812$56K0.0%+2,898.1%0.046% Get the Latest News and Ratings for NMRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neumora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/12/2025 AlphaCore Capital LLC337,767$248K0.0%N/A0.209% 8/12/2025 Catalyst Funds Management Pty Ltd39,400$29K0.0%N/A0.024% 8/11/2025 Universal Beteiligungs und Servicegesellschaft mbH55,659$41K0.0%N/A0.034% 8/8/2025 Geode Capital Management LLC916,815$673K0.0%-53.6%0.567% 8/6/2025 Savant Capital LLC70,432$52K0.0%N/A0.044% 8/1/2025 Y Intercept Hong Kong Ltd57,072$42K0.0%N/A0.035% 7/25/2025 CWM LLC35,750$26K0.0%+41.8%0.022% 7/25/2025 Vanguard Personalized Indexing Management LLC58,196$43K0.0%+130.3%0.036% 6/27/2025 Goldman Sachs Group Inc.607,784$608K0.0%-5.2%0.376% 5/23/2025 Siren L.L.C.4,358,283$4.36M0.3%-0.9%2.694% 5/16/2025 Goldman Sachs Group Inc.607,784$608K0.0%-5.2%0.376% 5/16/2025 AQR Capital Management LLC462,603$463K0.0%N/A0.286% 5/16/2025 ADAR1 Capital Management LLC26,108$26K0.0%-61.9%0.016% 5/15/2025 Graham Capital Management L.P.1,162,499$1.16M0.0%+1,643.7%0.719% 5/15/2025 Siren L.L.C.4,358,283$4.36M0.3%-0.9%2.694% 5/14/2025 Jump Financial LLC24,947$25K0.0%N/A0.015% 5/14/2025 T. Rowe Price Investment Management Inc.2,103,029$2.10M0.0%-58.0%1.300% 5/12/2025 Nuveen LLC220,970$221K0.0%N/A0.137% 5/12/2025 Aigen Investment Management LP36,360$36K0.0%N/A0.022% 5/12/2025 Virtu Financial LLC39,676$40K0.0%N/A0.025% 5/12/2025 Invesco Ltd.123,655$124K0.0%+151.1%0.076% 5/9/2025 Charles Schwab Investment Management Inc.593,498$593K0.0%-15.7%0.367% 5/8/2025 XTX Topco Ltd233,597$234K0.0%+969.7%0.144% 5/8/2025 Federated Hermes Inc.284,576$285K0.0%N/A0.176% 5/1/2025 CWM LLC25,213$25K0.0%+7,124.4%0.016% 4/30/2025 Cerity Partners LLC302,505$303K0.0%+24.0%0.187% 4/30/2025 Alps Advisors Inc.114,371$114K0.0%-12.5%0.071% 4/25/2025 Lunate Capital Ltd2,124,143$2.12M1.2%N/A1.313% 3/18/2025 California State Teachers Retirement System54,457$577K0.0%+793.5%0.034% 2/26/2025 Windmill Hill Asset Management Ltd104,373$1.11M0.4%+299.6%0.065% BREAKING: The House just passed 3 pro-crypto bills! (Ad)THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Discover the under-the-radar project I believe will skyrocket as a result.2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC72,622$770K0.0%N/A0.045% 2/17/2025 Wexford Capital LP252,122$2.67M0.4%+15.7%0.156% 2/17/2025 Toronto Dominion Bank34,300$364K0.0%N/A0.021% 2/17/2025 Stempoint Capital LP428,137$4.54M1.1%N/A0.265% 2/17/2025 Softbank Group CORP.6,541,190$69.34M0.3%-13.3%4.049% 2/17/2025 Rafferty Asset Management LLC17,431$185K0.0%N/A0.011% 2/17/2025 Numerai GP LLC51,696$548K0.2%+46.7%0.032% 2/17/2025 Orbimed Advisors LLC804,996$8.53M0.2%-46.3%0.498% 2/17/2025 Janus Henderson Group PLC26,500$281K0.0%N/A0.016% 2/17/2025 Graham Capital Management L.P.66,669$707K0.0%N/A0.041% 2/17/2025 Deutsche Bank AG73,103$775K0.0%+50.4%0.045% 2/17/2025 Cutter Capital Management LP150,000$1.59M0.7%N/A0.093% 2/17/2025 Brevan Howard Capital Management LP80,559$854K0.0%N/A0.050% 2/17/2025 BNP Paribas Financial Markets20,885$221K0.0%N/A0.013% 2/17/2025 Ameriprise Financial Inc.118,674$1.26M0.0%N/A0.073% 2/14/2025 PDT Partners LLC25,023$265K0.0%-20.1%0.015% 2/14/2025 Schonfeld Strategic Advisors LLC521,013$5.52M0.0%+273.9%0.322% 2/14/2025 Northern Trust Corp734,847$7.79M0.0%+7.7%0.455% 2/14/2025 The Manufacturers Life Insurance Company45,060$478K0.0%-59.0%0.028% 2/14/2025 T. Rowe Price Investment Management Inc.5,002,799$53.03M0.0%-4.3%3.097% 2/14/2025 Price T Rowe Associates Inc. MD32,548$346K0.0%-94.8%0.020% 2/14/2025 Soros Capital Management LLC279,333$2.96M0.5%-45.1%0.173% 2/14/2025 Rock Springs Capital Management LP955,106$10.12M0.4%+15.3%0.591% 2/14/2025 Capital International Investors3,700,359$39.22M0.0%+692.1%2.290% 2/13/2025 PEAK6 LLC11,057$117K0.0%N/A0.007% 2/13/2025 XTX Topco Ltd21,838$231K0.0%N/A0.014% 2/13/2025 Barclays PLC166,822$1.77M0.0%+29.1%0.103% 2/13/2025 Legal & General Group Plc59,842$634K0.0%+526.4%0.037% 2/13/2025 Invesco Ltd.49,249$522K0.0%+254.1%0.030% 2/13/2025 ADAR1 Capital Management LLC68,608$727K0.1%N/A0.042% 2/13/2025 Wells Fargo & Company MN70,653$749K0.0%+23.0%0.044% 2/12/2025 Geode Capital Management LLC1,970,280$20.89M0.0%-0.5%1.220% 2/12/2025 Franklin Resources Inc.31,357$332K0.0%-58.6%0.019% 2/12/2025 Alliancebernstein L.P.199,947$2.12M0.0%-10.3%0.124% 2/12/2025 Norges Bank110,000$1.17M0.0%N/A0.068% 2/11/2025 EntryPoint Capital LLC12,762$135K0.1%N/A0.008% 2/11/2025 Vanguard Group Inc.4,572,308$48.47M0.0%+4.5%2.830% 2/11/2025 KLP Kapitalforvaltning AS13,500$143K0.0%N/A0.008% 2/11/2025 Quantbot Technologies LP8,646$92K0.0%N/A0.005% 2/11/2025 Teacher Retirement System of Texas16,669$177K0.0%N/A0.010% 2/10/2025 Swiss National Bank110,200$1.17M0.0%N/A0.068% 2/7/2025 PNC Financial Services Group Inc.6,000$64K0.0%N/A0.004% 2/7/2025 AMG National Trust Bank43,379$480K0.0%N/A0.027% 2/7/2025 Candriam S.C.A.571,027$6.05M0.0%-15.6%0.353% 2/6/2025 Arizona State Retirement System16,222$172K0.0%N/A0.010% 2/6/2025 Charles Schwab Investment Management Inc.704,154$7.46M0.0%+0.8%0.436% 2/3/2025Callan Capital LLC636,194$6.74M0.5%-3.8%0.394% 2/3/2025 Ieq Capital LLC36,853$391K0.0%-50.8%0.023% 1/31/2025 Addis & Hill Inc163,386$1.73M1.3%-45.5%0.101% 1/28/2025 Windmill Hill Asset Management Ltd104,373$1.11M1.1%+299.6%0.065% BREAKING: The House just passed 3 pro-crypto bills! (Ad)THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Discover the under-the-radar project I believe will skyrocket as a result.1/27/2025 Mirae Asset Global Investments Co. Ltd.5,384$61K0.0%N/A0.003% 1/24/2025 SkyOak Wealth LLC20,000$212K0.0%+33.3%0.012% 1/24/2025China Universal Asset Management Co. Ltd.34,257$363K0.0%N/A0.021% 1/17/2025 SG Americas Securities LLC14,119$150K0.0%-34.6%0.009% 12/26/2024 JPMorgan Chase & Co.64,421$851K0.0%+2.6%0.040% 11/27/2024 Franklin Resources Inc.75,702$1M0.0%-13.9%0.047% 11/19/2024 Barclays PLC129,210$1.71M0.0%+352.9%0.080% 11/16/2024 Geode Capital Management LLC1,979,847$26.16M0.0%+54.0%1.225% 11/15/2024 Barclays PLC129,210$1.71M0.0%+352.9%0.080% 11/15/2024 Wexford Capital LP217,879$2.88M0.7%+90.1%0.135% (Data available from 1/1/2016 forward) NMRA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NMRA shares? During the previous two years, 109 institutional investors and hedge funds held shares of Neumora Therapeutics. The most heavily invested institutionals were FMR LLC ($102.37M), Softbank Group CORP. ($69.34M), Vanguard Group Inc. ($48.47M), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST ($46.69M), Artal Group S.A. ($40.21M), Capital International Investors ($39.22M), and Avidity Partners Management LP ($33.94M).Learn more on Neumora Therapeutics' institutional investors. What percentage of Neumora Therapeutics' stock is owned by institutional investors? 47.65% of Neumora Therapeutics' stock is owned by institutional investors. Learn more on NMRA's institutional investor holdings. Which institutional investors have been buying Neumora Therapeutics' stock? Of the 95 institutional investors that purchased Neumora Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($5.62M), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST ($3.31M), Capital International Investors ($3.23M), Lunate Capital Ltd ($2.12M), Avidity Partners Management LP ($1.99M), Graham Capital Management L.P. ($1.16M), and Johnson & Johnson ($912.13K). How much institutional buying is happening at Neumora Therapeutics? Institutional investors have bought a total of 14,851,254 shares in the last 24 months. This purchase volume represents approximately $104.66M in transactions. Which of Neumora Therapeutics' major shareholders have been selling company stock? Of the 23 institutional investors that sold Neumora Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: T. Rowe Price Investment Management Inc. ($3.13M), Geode Capital Management LLC ($1.07M), Softbank Group CORP. ($1.01M), FMR LLC ($873.31K), Bank of America Corp DE ($797.64K), Orbimed Advisors LLC ($695.00K), and Price T Rowe Associates Inc. MD ($592.93K). How much institutional selling is happening at Neumora Therapeutics? Institutional investors have sold a total of 9,205,795 shares in the last 24 months. This volume of shares sold represents approximately $50.85M in transactions. Related Companies Spyre Therapeutics Institutional Ownership Upstream Bio Institutional Ownership Stoke Therapeutics Institutional Ownership Verve Therapeutics Institutional Ownership Praxis Precision Medicines Institutional Ownership Valneva Institutional Ownership CorMedix Institutional Ownership Mineralys Therapeutics Institutional Ownership Nuvation Bio Institutional Ownership Oric Pharmaceuticals Institutional Ownership This page (NASDAQ:NMRA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neumora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neumora Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access